Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Juan, PR
NPI
1376630202
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
572 Calle de Diego, Sabana Llana
San Juan, PR, 00924
Phone (787) 754-9586
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
362 services
Medicare patients, 2024
133
Average age 76
Drug cost, 2024
$3.1M
9,807 prescriptions
Company payments, 2025
$1,227
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jorge R de Jesus Miranda was code 99214 (office e&m - established), 208 times for 105 patients. In total Jorge R de Jesus Miranda billed 362 services in 11 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 208 | 105 | $89.40 | $19K |
| 99213 Office E&M - Established | Office | 96 | 64 | $67.43 | $6,473 |
| 99204 Office E&M - New | Office | 25 | 25 | $114.08 | $2,852 |
| 95251 Test - Miscellaneous | Office | 19 | 12 | $26.86 | $510 |
By year: 2022 $19K for 373 services; 2023 $23K for 365 services; 2024 $29K for 362 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jorge R de Jesus Miranda prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,222 prescriptions and refills. In total Jorge R de Jesus Miranda wrote 9,807 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,222 | 3,020 | 389 | $133K |
| Trulicity Dulaglutide | 832 | 846 | 123 | $836K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 564 | 684 | 136 | $49K |
| Ozempic Semaglutide | 534 | 561 | 111 | $547K |
| Jardiance Empagliflozin | 473 | 663 | 122 | $403K |
| Metformin Hcl Er Metformin Hcl | 280 | 681 | 105 | $3,310 |
| Farxiga Dapagliflozin Propanediol | 259 | 312 | 62 | $182K |
| Rosuvastatin Calcium Generic | 244 | 664 | 90 | $4,123 |
| Atorvastatin Calcium Generic | 238 | 672 | 93 | $2,840 |
| Tradjenta Linagliptin | 220 | 291 | 63 | $152K |
| Metformin Hcl Generic | 203 | 568 | 81 | $2,114 |
| Humalog Insulin Lispro | 192 | 240 | 55 | $18K |
| Levothyroxine Sodium Generic | 189 | 524 | 66 | $3,249 |
| Gabapentin Generic | 186 | 390 | 75 | $2,323 |
| Losartan Potassium Generic | 185 | 503 | 74 | $2,431 |
Brand drugs: 5,716 claims; generic drugs: 3,754 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jorge R de Jesus Miranda $1,227 ($1,227 in general payments such as food, travel and fees) from 9 companies. The largest payer was Novo Nordisk Inc with $429.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 12 | $429 |
| Bayer Puerto Rico Inc. BAYN.DE | 8 | $171 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $146 |
| Lilly USA, LLC LLY | 1 | $120 |
| Medtronic, Inc. MDT | 1 | $66 |
| Abbott Laboratories ABT | 3 | $60.67 |
| Genzyme Corporation SNY | 1 | $43.16 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 1 | $24.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.